相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The KEAP1-NRF2 System as a Molecular Target of Cancer Treatment
Keiko Taguchi et al.
CANCERS (2021)
The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway
Liam Baird et al.
MOLECULAR AND CELLULAR BIOLOGY (2020)
Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death
S. Busker et al.
SCIENCE ADVANCES (2020)
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
Helmut Sies et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
The Complex Interplay between Antioxidants and ROS in Cancer
Isaac S. Harris et al.
TRENDS IN CELL BIOLOGY (2020)
To inhibit TrxR1 is to inactivate STAT3-Inhibition of TrxR1 enzymatic function by STAT3 small molecule inhibitors
Sander Busker et al.
REDOX BIOLOGY (2020)
NRF2 Regulation by Noncoding RNAs in Cancers: The Present Knowledge and the Way Forward
Federico Pio Fabrizio et al.
CANCERS (2020)
High Expression of NRF2 Is Associated with Increased Tumor-Infiltrating Lymphocytes and Cancer Immunity in ER-Positive/HER2-Negative Breast Cancer
Masanori Oshi et al.
CANCERS (2020)
Identification and targeting of selective vulnerability rendered by tamoxifen resistance
Madhurendra Singh et al.
BREAST CANCER RESEARCH (2020)
Thioredoxin-related protein of 14 kDa as a modulator of redox signalling pathways
Belen Espinosa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study
Suofu Ye et al.
SCIENTIFIC REPORTS (2019)
Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells
Paramita Chakraborty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
p53-Dependent Anti-Proliferative and Pro-Apoptotic Effects of a Gold(I) N-Heterocyclic Carbene (NHC) Complex in Colorectal Cancer Cells
Yasamin Dabiri et al.
FRONTIERS IN ONCOLOGY (2019)
Specific RITA Modification Produces Hyperselective Cytotoxicity While Maintaining In Vivo Antitumor Efficacy
Brian D. Peyser et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer
Wei Peng et al.
SCIENTIFIC REPORTS (2019)
Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization
Hae Lim Lee et al.
SCIENTIFIC REPORTS (2019)
Highlighted STAT3 as a potential drug target for cancer therapy
Haeri Lee et al.
BMB REPORTS (2019)
Regulation of redox balance in cancer and T cells
Hyewon Kong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Differential effects of the Nrf2 activators tBHQ and CDDO-Im on the early events of T cell activation
Joseph W. Zagorski et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Efficient selenocysteine-dependent reduction of toxoflavin by mammalian thioredoxin reductase
Radosveta Gencheva et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2018)
Nrf2 Activation Induced by Sirt1 Ameliorates Acute Lung Injury After Intestinal Ischemia/Reperfusion Through NOX4-Mediated Gene Regulation
DongDong Chai et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
The A to Z of modulated cell patterning by mammalian thioredoxin reductases
Markus Dagnell et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Significance of the mitochondrial thioredoxin reductase in cancer cells: An update on role, targets and inhibitors
Valeria Scalcon et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy
William C. Stafford et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Reactive Oxygen Species: Involvement in T Cell Signaling and Metabolism
Davide G. Franchina et al.
TRENDS IN IMMUNOLOGY (2018)
The thioredoxin-1 system is essential for fueling DNA synthesis during T-cell metabolic reprogramming and proliferation
Jonathan Muri et al.
NATURE COMMUNICATIONS (2018)
Metabolic Reprogramming in Modulating T Cell Reactive Oxygen Species Generation and Antioxidant Capacity
Josephin N. Rashida Gnanaprakasam et al.
FRONTIERS IN IMMUNOLOGY (2018)
Inhibition of the glutaredoxin and thioredoxin systems and ribonucleotide reductase by mutant p53-targeting compound APR-246
Lena Haffo et al.
SCIENTIFIC REPORTS (2018)
Thioredoxin reductase inhibitors: a patent review
Baoxin Zhang et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Mitochondrial targeted curcumin exhibits anticancer effects through disruption of mitochondrial redox and modulation of TrxR2 activity
Sundarraj Jayakumar et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Glutathione Primes T Cell Metabolism for Inflammation
Tak W. Mak et al.
IMMUNITY (2017)
Impaired cross-talk between the thioredoxin and glutathione systems is related to ASK-1 mediated apoptosis in neuronal cells exposed to mercury
Vasco Branco et al.
REDOX BIOLOGY (2017)
Reactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation
Dana M. Previte et al.
PLOS ONE (2017)
Oxidative Stress
Helmut Sies et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 86 (2017)
Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy
Hidemitsu Kitamura et al.
CANCER SCIENCE (2017)
Mitochondria-Targeted Approach: Remarkably Enhanced Cellular Bioactivities of TPP2a as Selective Inhibitor and Probe toward TrxR
Baoxia Liang et al.
ACS CHEMICAL BIOLOGY (2016)
Strategies and Approaches of Targeting STAT3 for Cancer Treatment
Stefanie L. Furtek et al.
ACS CHEMICAL BIOLOGY (2016)
Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters
Xupeng Bai et al.
DRUG METABOLISM REVIEWS (2016)
Details in the catalytic mechanism of mammalian thioredoxin reductase 1 revealed using point mutations and juglone-coupled enzyme activities
Jianqiang Xu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Serum thioredoxin reductase is highly increased in mice with hepatocellular carcinoma and its activity is restrained by several mechanisms
Le Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
PARADOXICAL ROLES OF ANTIOXIDANT ENZYMES: BASIC MECHANISMS AND HEALTH IMPLICATIONS
Xin Gen Lei et al.
PHYSIOLOGICAL REVIEWS (2016)
The thioredoxin system in breast cancer cell invasion and migration
Maneet Bhatia et al.
REDOX BIOLOGY (2016)
TrxR1 as a Potent Regulator of the Nrf2-Keap1 Response System
Marcus Cebula et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Cancer associated fibroblasts transfer lipids and proteins to cancer cells through cargo vesicles supporting tumor growth
Alice Santi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression
Isaac S. Harris et al.
CANCER CELL (2015)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
Reactive oxygen species in the tumor niche triggers altered activation of macrophages and immunosuppression: Role of fluoxetine
Sayan Ghosh et al.
CELLULAR SIGNALLING (2015)
Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405
Brandon L. Probst et al.
PLOS ONE (2015)
The conserved Trp114 residue of thioredoxin reductase 1 has a redox sensor-like function triggering oligomerization and crosslinking upon oxidative stress related to cell death
J. Xu et al.
CELL DEATH & DISEASE (2015)
APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
N. Mohell et al.
CELL DEATH & DISEASE (2015)
Dietary methionine can sustain cytosolic redox homeostasis in the mouse liver
Sofi Eriksson et al.
NATURE COMMUNICATIONS (2015)
Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells
Marijke C. C. Sachweh et al.
ONCOTARGET (2015)
Thioredoxin induces Tregs to generate an immunotolerant tumor microenvironment in metastatic melanoma
Xiaogang Wang et al.
ONCOIMMUNOLOGY (2015)
Nrf2 protects the lung against inflammation induced by titanium dioxide nanoparticles: A positive regulator role of Nrf2 on cytokine release
Norma L. Delgado-Buenrostro et al.
ENVIRONMENTAL TOXICOLOGY (2015)
Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling
Mirko C. Sobotta et al.
NATURE CHEMICAL BIOLOGY (2015)
Glutaredoxin 2 Reduces Both Thioredoxin 2 and Thioredoxin 1 and Protects Cells from Apoptosis Induced by Auranofin and 4-Hydroxynonenal
Huihui Zhang et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance
Benoit Tessoulin et al.
BLOOD (2014)
Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
Ho-June Lee et al.
CANCER CELL (2014)
sROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis
Y. Shi et al.
CELL DEATH AND DIFFERENTIATION (2014)
Nrf2 expression and activity in human T lymphocytes: stimulation by T cell receptor activation and priming by inorganic arsenic and tert-butylhydroquinone
Claudie Morzadec et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
STAT3 and metabolism: How many ways to use a single molecule?
Marco Demaria et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells
Y. Mao et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Mitochondrial-Targeted Curcuminoids: A Strategy to Enhance Bioavailability and Anticancer Efficacy of Curcumin
Cheruku Apoorva Reddy et al.
PLOS ONE (2014)
Thioredoxin-related protein of 14 kDa is an efficient L-cystine reductase and S-denitrosylase
Irina Pader et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Sec-containing TrxR1 is essential for self-sufficiency of cells by control of glucose-derived H2O2
X. Peng et al.
CELL DEATH & DISEASE (2014)
Hydrogen Peroxide As an Immunological Transmitter Regulating Autoreactive T Cells
Rikard Holmdahl et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
A Txnrd1-dependent metabolic switch alters hepatic lipogenesis, glycogen storage, and detoxification
Sonya V. Iverson et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Oncogenic functions of the transcription factor Nrf2
Irene Ganan-Gomez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Thioredoxin 1 Is Inactivated Due to Oxidation Induced by Peroxiredoxin under Oxidative Stress and Reactivated by the Glutaredoxin System
Yatao Du et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Truncated thioredoxin (Trx-80) promotes pro-inflammatory macrophages of the M1 phenotype and enhances atherosclerosis
Dler Faieeq Darweesh Mahmood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival
Chiara Gorrini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Selective activation of oxidized PTP1B by the thioredoxin system modulates PDGF-β receptor tyrosine kinase signaling
Markus Dagnell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase
X. Peng et al.
CELL DEATH & DISEASE (2013)
Oxidants, antioxidants and the current incurability of metastatic cancers
Jim Watson
OPEN BIOLOGY (2013)
Thioredoxin Reductase Inhibition Elicits Nrf2-Mediated Responses in Clara Cells: Implications for Oxidant-Induced Lung Injury
Morgan L. Locy et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase
Xiaoxiao Peng et al.
BIOCHEMICAL JOURNAL (2012)
Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1
Justin R. Prigge et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent
Lihui Wang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Glutathione and Glutaredoxin Act as a Backup of Human Thioredoxin Reductase 1 to Reduce Thioredoxin 1 Preventing Cell Death by Aurothioglucose
Yatao Du et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Keap 1-Nrf2 system in cancers: stress response and anabolic metabolism
Yoichiro Mitsuishi et al.
FRONTIERS IN ONCOLOGY (2012)
Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress
Dimitrios Mougiakakos et al.
BLOOD (2011)
The cap'n'collar transcription factor Nrf2 mediates both intrinsic resistance to environmental stressors and an adaptive response elicited by chemopreventive agents that determines susceptibility to electrophilic xenobiotics
Larry G. Higgins et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors
Oliver Rackham et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
Ruoning Wang et al.
IMMUNITY (2011)
Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling
Andrew G. Cox et al.
BIOCHEMICAL JOURNAL (2010)
Loss of Thioredoxin Reductase 1 Renders Tumors Highly Susceptible to Pharmacologic Glutathione Deprivation
Pankaj Kumar Mandal et al.
CANCER RESEARCH (2010)
The Selenium-independent Inherent Pro-oxidant NADPH Oxidase Activity of Mammalian Thioredoxin Reductase and Its Selenium-dependent Direct Peroxidase Activities
Qing Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Both Thioredoxin 2 and Glutaredoxin 2 Contribute to the Reduction of the Mitochondrial 2-Cys Peroxiredoxin Prx3
Eva-Maria Hanschmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regeneration
MaryClare F. Rollins et al.
JOURNAL OF CELL SCIENCE (2010)
Identification, Expression Pattern, and Characterization of Mouse Glutaredoxin 2 Isoforms
Christoph Hudemann et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death
Dimitrios Mougiakakos et al.
BLOOD (2009)
p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA
Elisabeth Hedstrom et al.
CELL CYCLE (2009)
High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy
Sofl E. Eriksson et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Crystal Structure and Catalysis of the Selenoprotein Thioredoxin Reductase 1
Qing Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Molecular Mechanisms of Thioredoxin and Glutaredoxin as Hydrogen Donors for Mammalian S Phase Ribonucleotide Reductase
Farnaz Zahedi Avval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Expression pattern of human glutaredoxin 2 isoforms:: Identification and characterization of two testis/cancer cell-specific isoforms
Maria Elisabet Lonn et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation
Andrew G. Cox et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia
S. Talbot et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Selenium compounds and selenoproteins in cancer
Regina Brigelius-Flohe
CHEMISTRY & BIODIVERSITY (2008)
Mitochondrial peroxiredoxin 3 is rapidly oxidized in cells treated
Kristin K. Brown et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
ROS and p53: A versatile partnership
Bin Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Transduction with the Antioxidant Enzyme Catalase Protects Human T Cells against Oxidative Stress
Takashi Ando et al.
JOURNAL OF IMMUNOLOGY (2008)
Gold(I)-mediated inhibition of protein tyrosine phosphatases:: A detailed in vitro and cellular study
Divya Krishnamurthy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Cell Death by SecTRAPs: Thioredoxin Reductase as a Prooxidant Killer of Cells
Karin Anestal et al.
PLOS ONE (2008)
Thioredoxin, produced by stromal cells retrieved from the lymph node microenvironment, rescues chronic lymphocytic leukemia cells from apoptosis in vitro
Eva Backman et al.
HAEMATOLOGICA (2007)
Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide
Jun Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mitochondrial respiratory chain and thioredoxin reductase regulate intermembrane Cu, Zn-superoxide dismutase activity:: implications for mitochondrial energy metabolism and apoptosis
Pedro Inarrea et al.
BIOCHEMICAL JOURNAL (2007)
Thioredoxin and related molecules - From biology to health and disease
Christopher Horst Lillig et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer
Hajime Nakamura et al.
SEMINARS IN CANCER BIOLOGY (2006)
The thioredoxin system in cancer
Elias S. J. Arner et al.
SEMINARS IN CANCER BIOLOGY (2006)
Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles
Pamela B. Cassidy et al.
CARCINOGENESIS (2006)
Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase
SI Hashemy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Effect of Auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase
MP Rigobello et al.
FREE RADICAL RESEARCH (2005)
Thioredoxin reductase is irreversibly modified by curcumin - A novel molecular mechanism for its anticancer activity
JG Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity
S Seemann et al.
ONCOGENE (2005)
Redox factor 1 (Ref-1) enhances specific DNA binding of p53 by promoting p53 tetramerization
S Hanson et al.
ONCOGENE (2005)
Truncated thioredoxin (Trx80) induces differentiation of human CD14+ monocytes into a novel cell type (TAMs) via activation of the MAP kinases p38, ERK, and JNK
K Pekkari et al.
BLOOD (2005)
Truncated thioredoxin: Physiological functions and mechanism
K Pekkari et al.
ANTIOXIDANTS & REDOX SIGNALING (2004)
Glutaredoxins: Glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system
AP Fernandes et al.
ANTIOXIDANTS & REDOX SIGNALING (2004)
Identification and characterization of TRP14, a thioredoxin-related protein of 14 kDa - New insights into the specificity of thioredoxin function
W Jeong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Roles of TRP14, a thioredoxin-related protein in tumor necrosis factor-α signaling pathways
W Jeong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Interactions of quinones with thioredoxin reductase -: A challenge to the antioxidant role of the mammalian selenoprotein
N Cenas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antioxidant treatment reduces expansion and contraction of antigen-specific CD8+ T cells during primary but not secondary viral infection
NG Laniewski et al.
JOURNAL OF VIROLOGY (2004)
Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt
H Murata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Thioredoxin reductase in human hepatoma cells is transcriptionally regulated by sulforaphane and other electrophiles via an antioxidant response element
KJ Hintze et al.
JOURNAL OF NUTRITION (2003)
Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase
PJ Moos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Reactive oxygen species differentially affect T cell receptor-signaling pathways
S Cemerski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation
G Angelini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: Selective regulation of mitogen-activated protein kinase activation and Fas ligand expression
S Devadas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
VJN Bykov et al.
NATURE MEDICINE (2002)
Reactive oxygen species, antioxidants, and the mammalian thioredoxin system
J Nordberg et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
The core promoter of human thioredoxin reductase 1
AK Rundlöf et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Chronic elevation of plasma thioredoxin: Inhibition of chemotaxis and curtailment of life expectancy in AIDS
H Nakamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Thioredoxin reductase as a pathophysiological factor and drug target
K Becker et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Structure and mechanism of mammalian thioredoxin reductase:: The active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence
LW Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
